Please login to the form below
Ketchum Pleon
This page shows the latest Ketchum Pleon news and features for those working in and with pharma, biotech and healthcare.
Experience = innovation
Client:Bristol-Myers Squibb. Agency:Ketchum Pleon . Campaign:EVOLUT10N: A decade of experience, a future of innovation.
Latest news
More from news
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest Intelligence
-
Data-driven pharma marketing
The Authors. Andrew Lamb, Digital Strategist – Healthcare, Ketchum Pleon and Inspired Science andrew.lamb@inspiredscience.com. ... Melissa Wolfe, Social Media Strategist &Analyst, Ketchum Pleon Melissa.Wolfe@ketchumpleon.com.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest appointments
-
Ketchum names new global healthcare practice director
Ketchum Pleon has promoted its London healthcare MD, Amanda Sefton, to global director of the healthcare practice. ... internal comms firm Ketchum Pleon Change.
-
Harry King joins senior healthcare team at Ketchum Pleon
Comms consultancy also appoints Julie Dawson-Wills. Ketchum Pleon has appointed Harry King (pictured) as practice director for its healthcare team. ... Amanda Sefton, MD of healthcare at Ketchum Pleon in London, said: “Harry is an exceptional
More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.
Latest from PMHub
-
HealthCheck with Professor Peter Piot
The author of No Time to Lose was interviewed as part of Ketchum and Inspired Science's HealthCheck series.
-
Ketchum
At Ketchum, we’re inspired to use communications to break through the way the world responds to brands, reputations and ideas.This has led to strong, long-standing relationships with our
-
Inspired Science
As a part of the global Omnicom network, and a strategic partner to Ketchum Pleon, Inspired Science has access to the.
Ketchum
Inspired Science
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Account Supervisor – Leading Healthcare Advertising Agency – New...
-
Highly Competitive Salary, Bonus &Benefits
- Principal Medical Writer, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Vaccines writer – career opportunity to move into medcomms from ...
-
Highly competitive salary
- Senior Medical Writer – Creative Healthcare Advertising – New Yo...
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writers > Scientific Directors – Medical Communicatio...
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Senior Account Exec > CSD – Medical Communications – UK, Lond...
-
Highly Competitive Salary, Bonus &Benefits
- Scientific Director, MRNA/ Covid 19, Medical Communications, UK
-
Six figure salary
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- First trial of a vaccine against Alzheimer’s launches
- Gilead’s Trodelvy approved for triple-negative breast cancer in Europe
- US government to pay $5.3bn for Pfizer‘s Paxlovid
- Gilead to pay $745m for three oncology programmes from Arcus Biosciences
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Roche to present new data for its drug Polivy at the American Society of Hematology’s annual meeting
- Lucid Group: Orange the World
- First trial of a vaccine against Alzheimer’s launches
- New COVID variant causing concern
- PMEA 2021: A Celebration of Excellence in Patient Engagement
- From Academics to Entrepreneurship: How Tech is Revolutionizing the Diagnostics Landscape
- Impetus Digital wins Canada’s Most Admired Corporate Cultures Awards 2021
- Results for Merck’s oral cholesterol inhibitor show it to be ‘highly effective’
- Biogen’s Aduhelm unlikely to get approval in Europe
- Gilead’s Trodelvy approved for triple-negative breast cancer in Europe
- The pandemic preparedness paradox
- First trial of a vaccine against Alzheimer’s launches
- Good NICE news for Pfizer, but Dendreon drug rejected
PMHub
Mind+Matter
We are Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for our...
Latest intelligence
- Webinar:
- Securing a future for telehealth with immersive market research insights...
- Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
- How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
- Six ways to improve diversity in clinical trials
- Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...
